Figure 4From: A novel multiplex assay combining autoantibodies plus PSA has potential implications for classification of prostate cancer from non-malignant casesAn ROC curve comparing the A+PSA index and total PSA alone in differentiating the same group of prostate cancer and BPH/prostatitis patients as shown in Figure 3. The distribution of total PSA values in samples used in this study are shown in Figure 1S.Back to article page